ストックスクリーナーアプリを入手
1.7709
3.23%
-0.0591
アフターアワーズ：
1.86
0.0891
+5.03%
前日終値:
$1.83
開ける：
$1.63
24時間の取引高:
120.08K
Relative Volume:
4.90
時価総額：
$413.88M
収益：
$2.35M
当期純損益:
$-2.56M
株価収益率:
-3.952
EPS:
-0.4481
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.30%
1か月 パフォーマンス:
-5.05%
6か月 パフォーマンス:
-7.12%
1年 パフォーマンス:
-23.67%
1日の値動き範囲:
$1.63
$1.95
1週間の範囲:
$1.63
$1.95
52週間の値動き範囲:
$1.50
$2.87
Immuron Limited Adr Stock (IMRN) Company Profile
IMRN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMRN
Immuron Limited Adr
|
1.7709 | 10.83M | 2.35M | -2.56M | 0 | -0.4481 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Immuron Limited Adr (IMRN) 最新ニュース
Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider
Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network
Immuron to Present at Q4 Virtual Investor Summit: Gut Disease Pipeline Showcase | IMRN Stock News - StockTitan
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire
Immuron Plans Phase 2 Trial for IMM-529 following FDA review - GlobeNewswire
Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK
Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard
Immuron US DoD Naval Medical Research Center responds to - GlobeNewswire
Immuron Surges On U.S. DoD Funding For Travelan Research By Investing.com - Investing.com Nigeria
Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan
Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq
IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan
Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire
Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33% - Investing.com
Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire
IMC Stock Price and Chart — ASX:IMC - TradingView
Immuron Limited Adr (IMRN) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):